Poddar Abhijit, Rao S R
Centre for Bio-Policy Research (CBPR), MGM Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be-University), Pondicherry, India; Genentech Regulatory Solutions LLP, Hyderabad, India.
Genentech Regulatory Solutions LLP, Hyderabad, India.
J Cancer Policy. 2025 Mar;43:100521. doi: 10.1016/j.jcpo.2024.100521. Epub 2024 Nov 13.
India's ambitious goal of eliminating cervical cancer by 2030 faces significant challenges due to the high burden of disease, low screening rates, and sociocultural barriers. Despite the Government's focus on vaccination, addressing cervical cancer requires a more comprehensive approach that is multisectoral and consider practice to policy engagement. Addressing not only vaccination but also social barriers, healthcare infrastructure, and research is key to preventing and controlling this preventable disease. Fragmented health policies with limited coverage for cervical cancer, coupled with societal issues like stigma and limited access to healthcare, particularly in rural areas, pose significant challenges. Moreover, limited awareness of HPV and vaccines hinders progress. To effectively combat cervical cancer, India must prioritize a readiness assessment to evaluate past interventions, economic feasibility, and social issues before launching new programs. Improving healthcare infrastructure, training healthcare workers, and utilizing innovative models like mobile clinics can expand access to care. Public-private partnerships with incentives can also play a crucial role in mobilizing resources. Investing in culturally appropriate public awareness campaigns is essential to educate the population about HPV, cervical cancer, and prevention strategies. A robust pharmacovigilance program is necessary to ensure vaccine safety. Additionally, India should invest in science and technology to support long-term research efforts, while increasing understanding of population-specific predisposing factors for broader-spectrum vaccines and personalized approaches. A dedicated national policy with clear objectives, strategies, and accountability mechanisms is crucial for successful cervical cancer control. Learning from the experiences of other countries can inform policy development.
印度到2030年消除宫颈癌的宏伟目标面临重大挑战，原因包括疾病负担高、筛查率低以及社会文化障碍。尽管政府专注于疫苗接种，但应对宫颈癌需要一种更全面的多部门方法，并考虑从实践到政策的参与。不仅要解决疫苗接种问题，还要解决社会障碍、医疗基础设施和研究问题，这是预防和控制这种可预防疾病的关键。宫颈癌相关卫生政策碎片化，覆盖范围有限，再加上耻辱感和医疗服务可及性有限等社会问题，尤其是在农村地区，构成了重大挑战。此外，对人乳头瘤病毒（HPV）和疫苗的认识有限也阻碍了进展。为有效抗击宫颈癌，印度必须在启动新计划之前优先进行准备情况评估，以评估过去的干预措施、经济可行性和社会问题。改善医疗基础设施,培训医护人员，并利用移动诊所等创新模式可以扩大医疗服务的可及性。有激励措施的公私伙伴关系在调动资源方面也可以发挥关键作用。投资开展符合文化背景的公众宣传活动对于教育民众了解HPV、宫颈癌和预防策略至关重要。强大的药物警戒计划对于确保疫苗安全是必要的。此外，印度应投资于科学技术以支持长期研究工作，同时加深对特定人群更广泛疫苗和个性化方法的易感因素的了解。一项具有明确目标、战略和问责机制的专门国家政策对于成功控制宫颈癌至关重要。借鉴其他国家的经验可为政策制定提供参考。
